(Northwestern University) Scientists have discovered that a subset of immune cells called nonclassical monocytes, previously unknown to reside in the lungs, play a key role in driving primary graft dysfunction (PGD), the leading cause of death after lung transplantation. The study demonstrates targeting these cells could lead to novel treatments for PGD, a complication that currently impacts more than half of transplant patients.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2t2Z6X4
No comments:
Post a Comment